Open AccessInflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy
Author(s) -
Jason V. Baker,
Jacqueline Neuhaus,
Daniel Duprez,
David A. Cooper,
Jennifer Hoy,
Lewis H. Kuller,
Fiona Lampe,
Angelike P. Liappis,
Nina Friis-Møller,
James D. Otvos,
Nick Paton,
Russell P. Tracy,
James D. Neaton
Publication year - 2011
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32834be088
Subject(s) - antiretroviral therapy , medicine , inflammation , apolipoprotein b , human immunodeficiency virus (hiv) , lipoprotein , immunology , cholesterol , viral load
The effects of HIV infection and antiretroviral therapy (ART) on usual lipid levels have been reported. The effects of initiating versus deferring ART on high-density and low-density lipoprotein particle (HDL-P and LDL-P, respectively) concentrations and apolipoprotein (Apo) levels are not well described.